Industries Expertise Posts

Chemical companies are investing heavily in digital capabilities, yet commercial decisions often remain slow and inconsistent. Discover why Commercial Decision Intelligence—not simply more data—is becoming the next competitive

Pricing pressure is not the root problem. It is exposing weaknesses in Pricing Governance, gross-to-net transparency, and commercial operating models. Discover why leading pharmaceutical organizations are responding through Commercial Transformation.

Many Transport & Logistics companies have optimized operations but still struggle to improve profitability. The challenge increasingly lies in pricing governance, customer profitability visibility, and commercial decision architecture.

Technology companies generate enormous amounts of data, yet many still struggle with margin leakage and inconsistent commercial execution. Commercial Transformation provides the structure needed to convert information into disciplined, profitable decisions.

Financial institutions face growing pressure to improve profitability while managing increasing commercial complexity. Discover how Commercial Transformation helps align strategy, pricing, governance, execution, and AI-Powered systems to create measurable business impact.

Industrial organizations are facing growing pressure from fragmented pricing governance, operational complexity, and disconnected commercial execution. This article explores why Commercial Transformation is becoming a structural operating discipline across industrial sectors.

Commercial complexity in Animal Health is accelerating across pricing, distribution, commercial governance, and execution models. In this executive perspective, Stratence Partners explores why Commercial Transformation is becoming a structural capability for organizations seeking sustainable profitability and disciplined growth.

Medical Devices organizations are facing growing margin pressure not because pricing teams are failing, but because commercial governance structures are increasingly fragmented. Stratence Partners explores why Commercial Transformation has become a structural operating necessity.

Utilities companies are facing structural margin erosion not due to strategy failure, but execution gaps. Discover how Commercial Transformation restores control.

Oil & Gas margin erosion is no longer driven by market volatility alone, but by fragmented commercial execution. This article explains why Commercial Transformation is now critical.

Chemical companies are losing control over pricing and margins. Discover how Commercial Transformation restores visibility, governance, and execution discipline.

Pharma is not facing a pricing problem, but a fragmented commercial system. Discover why CEOs must now lead Commercial Transformation as an integrated operating model.

Transport & Logistics is no longer an operational challenge. It is a Commercial Transformation challenge.

IT companies lose up to 12% of EBIT due to fragmented commercial decisions. Learn how structured Commercial Transformation restores control, transparency and profitability.

Financial Services organizations lose up to 12% of EBIT due to fragmented commercial decisions. Discover how an integrated Commercial Transformation approach restores control, transparency, and profitability.

Industrial Manufacturing is no longer defined by operational excellence alone. Discover how leading organizations are achieving measurable EBIT impact through Commercial Transformation and AI Powered decision systems.

Animal Health companies face structural margin erosion from fragmented pricing, opaque gross-to-net dynamics, and misaligned execution. AI-Powered Commercial Transformation is no longer optional — it is strategic.

In Medical Devices, margin erosion rarely comes from innovation. It comes from fragmented commercial governance. Stratence Partners explains how Commercial Transformation, AI Powered, restores structural control and delivers measurable EBIT impact within year one.

In Oil & Gas, margin erosion is rarely caused by strategy. It is caused by weak execution, fragmented pricing governance and disconnected commercial decisions.

Volatility has become structural in the Chemical industry. This article explores how leading players are strengthening pricing governance and commercial execution to protect margins and turn complexity into competitive advantage.